<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is an aggressive B cell <z:hpo ids='HP_0002664'>neoplasm</z:hpo>, which is one of the most common <z:hpo ids='HP_0002664'>neoplasms</z:hpo> of childhood </plain></SENT>
<SENT sid="1" pm="."><plain>It is highly widespread in East Africa, where it appears in endemic form associated with Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, and around the world in a <z:hpo ids='HP_0003745'>sporadic</z:hpo> form in which <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> is much less common </plain></SENT>
<SENT sid="2" pm="."><plain>In addition to being the first human <z:hpo ids='HP_0002664'>neoplasm</z:hpo> to be associated with EBV, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> is associated with a characteristic translocation, in which the Ig promoter is translocated to constitutively activate the c-myc oncogene </plain></SENT>
<SENT sid="3" pm="."><plain>Although many <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> respond well to chemotherapy, a significant fraction fails to respond to therapy, leading to <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In this article, we demonstrate that EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> expresses high levels of activated <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase and reactive oxygen species (ROS), and that ROS directly regulate NF-kappaB activation </plain></SENT>
<SENT sid="5" pm="."><plain>EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> exhibit activation of phosphoinositol 3-kinase, but do not have elevated levels of ROS </plain></SENT>
<SENT sid="6" pm="."><plain>Elevated reactive oxygen may play a role in diverse forms of <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in humans, including <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> caused by EBV, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B, C, and human T cell lymphotropic virus </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings imply that inhibition of ROS may be useful in the treatment of EBV-induced <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
</text></document>